Immune infiltration profiling in gastric cancer and their clinical implications.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3569, doi. 10.1111/cas.15057
- By:
- Publication type:
- Article
Works matching AU Zhao, Qitai
Results: 22
1
2
Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00424-x
- By:
- Publication type:
- Article
3
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3811, doi. 10.1002/cam4.2312
- By:
- Publication type:
- Article
4
Screening common signaling pathways associated with drug resistance in non‐small cell lung cancer via gene expression profile analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 6, p. 3059, doi. 10.1002/cam4.2190
- By:
- Publication type:
- Article
5
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.
- Published in:
- Immunology & Cell Biology, 2019, v. 97, n. 5, p. 457, doi. 10.1111/imcb.12225
- By:
- Publication type:
- Article
6
Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma.
- Published in:
- Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03725-x
- By:
- Publication type:
- Article
7
Peripheral CX3CR1<sup>+</sup> T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer.
- Published in:
- OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2355684
- By:
- Publication type:
- Article
8
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.
- Published in:
- OncoImmunology, 2018, v. 7, n. 7, p. 1, doi. 10.1080/2162402X.2018.1442167
- By:
- Publication type:
- Article
9
Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer.
- Published in:
- MedComm, 2025, v. 6, n. 3, p. 1, doi. 10.1002/mco2.70100
- By:
- Publication type:
- Article
10
A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues.
- Published in:
- Scientific Data, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41597-024-03885-x
- By:
- Publication type:
- Article
11
A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03689-3
- By:
- Publication type:
- Article
12
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2663, doi. 10.1007/s00262-022-03193-6
- By:
- Publication type:
- Article
13
Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2601, doi. 10.1007/s00262-021-02872-0
- By:
- Publication type:
- Article
14
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2371, doi. 10.1007/s00262-020-02629-1
- By:
- Publication type:
- Article
15
L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 2, p. 547, doi. 10.20892/j.issn.2095-3941.2020.0182
- By:
- Publication type:
- Article
16
Single-cell RNA sequencing analysis reveals a lack of CXCL13<sup>+</sup> T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04083-3
- By:
- Publication type:
- Article
17
Single-cell RNA sequencing analysis reveals a lack of CXCL13<sup>+</sup> T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04083-3
- By:
- Publication type:
- Article
18
Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03904-1
- By:
- Publication type:
- Article
19
Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.661357
- By:
- Publication type:
- Article
20
Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 3, p. 2738, doi. 10.1002/jcp.29177
- By:
- Publication type:
- Article
21
Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1572040
- By:
- Publication type:
- Article
22
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01388-6
- By:
- Publication type:
- Article